SDS Abbdia 08K2827 Architect BNP Reagent Kit
SDS Abbdia 08K2827 Architect BNP Reagent Kit
Product Name
Components:
8K28G ARCHITECT BNP Coated Microparticles
8K28H ARCHITECT BNP Conjugate
8K28J ARCHITECT BNP Specimen Diluent
Abbott Customers:
For additional information, please contact your Abbott Customer Support Center Representative by calling 1-800-527-1869,
1-800-323-9100, or 1-800-235-5396.
Abbott employees:
For additional information relative to the content of the MSDSs, please contact your local Safety Representative.
Page 1/9
* 1 Identification
· Product name: ARCHITECT BNP Coated Microparticles
* 2 Hazard(s) identification
· Classification of the substance or mixture
· Classification system:
The classification was made according to U.S. OSHA 29 CFR 1910.1200 and 1910.1030 and applicable
European regulations, and is expanded upon from company and/or literature data.
· Label elements
· Labelling according to EU guidelines:
· Code letter and hazard designation of product:
Xi Irritant
37.0.4
Page 2/9
* 3 Composition/information on ingredients
· Chemical characterization: Mixture of chemical and/or biological substances for in vitro diagnostic use.
· Hazardous chemical ingredients per U.S. OSHA criteria (29 CFR 1910.1200 Hazard Communication):
2682-20-4 2-Methyl-2H-isothiazol-3-one 0.0094%
* 4 First-aid measures
· General information: Immediately remove any clothing soiled by the product.
· After inhalation: Remove from source of exposure. If irritation or signs of toxicity occur, seek medical attention.
· After skin contact:
Take off any clothing that the product touched.
Rinse skin with running water for 15 to 20 minutes. Seek medical attention if irritation or signs of toxicity occur.
· After eye contact:
Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
If eye irritation persists, get medical advice/attention. Wash hands after handling.
· After swallowing: Rinse mouth with water. If irritation or signs of toxicity occur, seek medical attention.
· Information for Medical Personnel
· Most important symptoms and effects, both acute and delayed:
Allergic reactions
Possibly immune response
This product may cause skin sensitization reactions in some people. See Section 11 for additional information.
· Medical conditions aggravated by exposure:
Pre-existing skin ailments
Skin allergies
USA
37.0.4
Page 3/9
* 5 Fire-fighting measures
· Suitable extinguishing agents
Dry chemical, carbon dioxide (CO2), water spray or regular foam.
- Caution: CO2 will displace air in confined spaces and may cause an oxygen-deficient atmosphere.
- For larger fires: There are no unique chemical or reactivity hazards that would impact firefighting decisions related
to this product. Use firefighting measures that suit the environment.
· Special hazards arising from the substance or mixture
There are no unique chemical or reactivity hazards that would impact firefighting decisions due to the chemicals in this
product.
· Protective equipment
For large fires, wear appropriate heat- and flame-resistant personal protective equipment and a NFPA/NIOSH
approved positive-pressure, self-contained breathing apparatus.
37.0.4
Page 4/9
Small-volume spills (e.g. small enough to clean up with a paper towel or small sorbent pad) - respiratory protection
should not be necessary if room is well ventilated.
Other unusual conditions (e.g. volume spilled too big to clean up with materials in arm's reach) - Use appropriate
NIOSH-approved air-purifying respirator if airborne chemical concentrations may exceed the exposure limit (if any)
listed above.
37.0.4
Page 5/9
37.0.4
Page 6/9
* 11 Toxicological information
· Acute toxicity
· LD50/LC50 values for hazardous ingredients per OSHA criteria:
· Ingredients (100% pure substance/s):
2682-20-4 2-Methyl-2H-isothiazol-3-one
Oral LD50 60 mg/kg (mouse)
By analogy to methylchloroisothiazolinone.
53 mg/kg (rat)
By analogy to methylchloroisothiazolinone.
· Primary toxicological effects of the final product:
· Skin irritation: No irritant effect.
· Eye irritation: No irritant effect.
· Sensitization:
Skin sensitization is possible with prolonged exposure, based on the reported properties of methylisothiazolones.
· Additional toxicological information: None
· Carcinogenic categories
· IARC (International Agency for Research on Cancer)
None of the ingredients is listed.
· NTP (National Toxicology Program)
None of the ingredients is listed.
· Target organs/systems:
Skin
Immune system
* 12 Ecological information
· Aquatic toxicity: No further relevant information available.
USA
37.0.4
Page 7/9
* 13 Disposal considerations
· Recommendation for disposal of unused product:
Dispose in accordance with federal, state and local regulations and institutional requirements. Waste containing
this product may be considered hazardous per U.S. EPA, state or local regulations. The following may be
particularly important when identifying appropriate disposal:
- Contains sodium azide. See Section 10 when considering how to appropriately dispose of unused product. For
drain systems with pipes or solder containing copper, lead, brass and/or silver, flush drains thoroughly with
copious amounts of water to prevent the formation of potentially explosive metal azides in plumbing. Detailed
information about azides in drains is available from the U.S. NIOSH Current Intelligence Bulletin No. 13 (August
16, 1976).
· Recommendation for disposal of packaging:
Non-contaminated packaging may be used for recycling. Refer to applicable local regulations and institutional
policies.
For disposal of contaminated packaging, refer to applicable local regulations and institutional policies.
· Recommended cleansing agent: Water with cleansing agents, if necessary.
* 14 Transport information
· DOT, ADN, IMDG, IATA none
· UN proper shipping name
· DOT, ADR, ADN, IMDG, IATA none
· Transport hazard class(es)
· DOT, ADR, ADN, IMDG, IATA
· Class none
· DOT, IMDG, IATA none
· Environmental hazards
· Marine pollutant: No
· Additional information
· DOT
· Remarks: Not restricted for transportation.
· ADR
· Remarks: Not restricted for transportation.
· IMDG
· Remarks: Not restricted for transportation.
USA
37.0.4
Page 8/9
· IATA
· Remarks: Not restricted for transportation.
* 15 Regulatory information
· SARA (Superfund Amendments and Reauthorization Act of 1986 - USA):
· Section 302/304 (40CFR355.30 / 40CFR355.40):
26628-22-8 Sodium azide
· Section 313 (40CFR372.65):
26628-22-8 Sodium azide
· California Proposition 65 (USA):
· Chemicals known to cause cancer:
The product does not contain listed substances.
· Chemicals known to cause female reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause male reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause developmental reproductive toxicity:
None of the ingredients is listed.
* 16 Other information
The information and recommendations contained herein are based upon information or tests believed to be reliable.
Abbott Laboratories does not guarantee the accuracy or completeness of this information or recommendations
contained herein, NOR SHALL ANY OF THIS INFORMATION CONSTITUTE A WARRANTY, WHETHER
EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE MERCHANTABILITY OF THE GOODS,
OR THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE.
This information is not a substitute for the advice of a health care professional, nor is it a recommendation for any
particular course of treatment. It is not intended to supplement, modify or supersede any information (e.g. labeling
and package inserts) provided with respect to the medical use of the product. Abbott Laboratories assumes no
responsibility for results obtained or for incidental or consequential damages, including lost profits, arising from the
use of these data. No warranty against infringement of any patent, copyright or trademark is made or implied.
· Department issuing MSDS
- Abbott Diagnostics Safety, Health and Environmental Assurance
Department 0571
· Contact
USA
37.0.4
Page 9/9
37.0.4
Page 1/9
* 1 Identification
· Product name: ARCHITECT BNP Conjugate
* 2 Hazard(s) identification
· Classification of the substance or mixture
· Classification system:
The classification was made according to U.S. OSHA 29 CFR 1910.1200 and 1910.1030 and applicable
European regulations, and is expanded upon from company and/or literature data.
· Label elements
· Labelling according to EU guidelines:
· Code letter and hazard designation of product:
Xi Irritant
37.0.4
Page 2/9
* 3 Composition/information on ingredients
· Chemical characterization: Mixture of chemical and/or biological substances for in vitro diagnostic use.
· Hazardous chemical ingredients per U.S. OSHA criteria (29 CFR 1910.1200 Hazard Communication):
9002-93-1 Polyethylene glycol octylphenyl ether 0.9524%
55965-84-9 Reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7] and 2-methyl- 0.0034%
2H -isothiazol-3-one [EC no. 220-239-6] (3:1);
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7] and 2-methyl-4-
isothiazolin-3-one [EC no. 220-239-6] (3:1)
* 4 First-aid measures
· General information: Immediately remove any clothing soiled by the product.
· After inhalation: Remove from source of exposure. If irritation or signs of toxicity occur, seek medical attention.
· After skin contact:
Take off any clothing that the product touched.
Rinse skin with running water for 15 to 20 minutes. Seek medical attention if irritation or signs of toxicity occur.
· After eye contact:
Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
If eye irritation persists, get medical advice/attention. Wash hands after handling.
· After swallowing: Rinse mouth with water. If irritation or signs of toxicity occur, seek medical attention.
· Information for Medical Personnel
· Most important symptoms and effects, both acute and delayed:
Allergic reactions
Possibly immune response
This product may cause skin sensitization reactions in some people. See Section 11 for additional information.
· Medical conditions aggravated by exposure:
Pre-existing skin ailments
USA
37.0.4
Page 3/9
Skin allergies
* 5 Fire-fighting measures
· Suitable extinguishing agents
Dry chemical, carbon dioxide (CO2), water spray or regular foam.
- Caution: CO2 will displace air in confined spaces and may cause an oxygen-deficient atmosphere.
- For larger fires: There are no unique chemical or reactivity hazards that would impact firefighting decisions related
to this product. Use firefighting measures that suit the environment.
· Special hazards arising from the substance or mixture
There are no unique chemical or reactivity hazards that would impact firefighting decisions due to the chemicals in this
product.
· Protective equipment
For large fires, wear appropriate heat- and flame-resistant personal protective equipment and a NFPA/NIOSH
approved positive-pressure, self-contained breathing apparatus.
37.0.4
Page 4/9
Dispose of spilled and contaminated material in accordance with Federal, State, and Local regulations. See Section
13 for information that may impact disposal of materials contaminated with this product.
· Reference to other sections
See Section 7 for information on safe handling
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.
Small-volume spills (e.g. small enough to clean up with a paper towel or small sorbent pad) - respiratory protection
should not be necessary if room is well ventilated.
Other unusual conditions (e.g. volume spilled too big to clean up with materials in arm's reach) - Use appropriate
NIOSH-approved air-purifying respirator if airborne chemical concentrations may exceed the exposure limit (if any)
listed above.
37.0.4
Page 5/9
· Hand protection:
Wear impervious gloves if hand contact with the material is anticipated. Dispose of contaminated gloves after use
in accordance with applicable laws and good laboratory practices.
· Material of gloves and breakthrough time of the glove material:
The glove material must be suitable for use in a microbiological laboratory and have a measured breakthrough
time of at least 30 minutes, such as those with a Class 2 protection index per EN374 (or equivalent standard
applicable in your region). NOTE: This recommendation applies only to the product stated in this Safety Data
Sheet. When dissolving in or mixing with other substances, contact the supplier of approved gloves.
· Eye protection:
Wear safety glasses or other protective eyewear. If splash potential exists, wear full face shield or goggles.
· Body protection:
Normal use: protect personal clothing from spatters and small spills. Wear a laboratory coat (or other protective
clothing required by your institution).
Larger spills (e.g. that can saturate cloth): wear appropriate water-repellant covering over clothing.
37.0.4
Page 6/9
* 11 Toxicological information
· Acute toxicity
· LD50/LC50 values for hazardous ingredients per OSHA criteria:
· Ingredients (100% pure substance/s):
9002-93-1 Polyethylene glycol octylphenyl ether
Oral LD50 1800 mg/kg (rat)
· Primary toxicological effects of the final product:
· Skin irritation: No irritant effect.
· Eye irritation: No irritant effect.
· Sensitization:
Skin sensitization is possible with prolonged exposure, based on the reported properties of methylisothiazolones.
· Additional toxicological information: None
· Carcinogenic categories
· IARC (International Agency for Research on Cancer)
None of the ingredients is listed.
· NTP (National Toxicology Program)
None of the ingredients is listed.
· Target organs/systems:
Skin
Immune system
USA
37.0.4
Page 7/9
* 12 Ecological information
· Aquatic toxicity: No further relevant information available.
· Additional ecological information
· General notes:
Do not allow undiluted product or large quantities of it to reach ground water, water course, or sewage system.
· Results of PBT and vPvB assessment
· PBT: Not applicable
· vPvB: Not applicable
* 13 Disposal considerations
· Recommendation for disposal of unused product:
Dispose in accordance with federal, state and local regulations and institutional requirements. Waste containing
this product may be considered hazardous per U.S. EPA, state or local regulations. The following may be
particularly important when identifying appropriate disposal:
- Contains sodium azide. See Section 10 when considering how to appropriately dispose of unused product. For
drain systems with pipes or solder containing copper, lead, brass and/or silver, flush drains thoroughly with
copious amounts of water to prevent the formation of potentially explosive metal azides in plumbing. Detailed
information about azides in drains is available from the U.S. NIOSH Current Intelligence Bulletin No. 13 (August
16, 1976).
· Recommendation for disposal of packaging:
Non-contaminated packaging may be used for recycling. Refer to applicable local regulations and institutional
policies.
For disposal of contaminated packaging, refer to applicable local regulations and institutional policies.
· Recommended cleansing agent: Water with cleansing agents, if necessary.
* 14 Transport information
· DOT, ADN, IMDG, IATA none
· UN proper shipping name
· DOT, ADR, ADN, IMDG, IATA none
· Transport hazard class(es)
· DOT, ADR, ADN, IMDG, IATA
· Class none
· DOT, IMDG, IATA none
· Environmental hazards
· Marine pollutant: No
· Additional information
· DOT
· Remarks: Not restricted for transportation.
USA
37.0.4
Page 8/9
· ADR
· Remarks: Not restricted for transportation.
· IMDG
· Remarks: Not restricted for transportation.
· IATA
· Remarks: Not restricted for transportation.
* 15 Regulatory information
· SARA (Superfund Amendments and Reauthorization Act of 1986 - USA):
· Section 302/304 (40CFR355.30 / 40CFR355.40):
26628-22-8 Sodium azide
· Section 313 (40CFR372.65):
26628-22-8 Sodium azide
· California Proposition 65 (USA):
· Chemicals known to cause cancer:
The product does not contain listed substances.
· Chemicals known to cause female reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause male reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause developmental reproductive toxicity:
None of the ingredients is listed.
* 16 Other information
The information and recommendations contained herein are based upon information or tests believed to be reliable.
Abbott Laboratories does not guarantee the accuracy or completeness of this information or recommendations
contained herein, NOR SHALL ANY OF THIS INFORMATION CONSTITUTE A WARRANTY, WHETHER
EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE MERCHANTABILITY OF THE GOODS,
OR THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE.
This information is not a substitute for the advice of a health care professional, nor is it a recommendation for any
particular course of treatment. It is not intended to supplement, modify or supersede any information (e.g. labeling
and package inserts) provided with respect to the medical use of the product. Abbott Laboratories assumes no
responsibility for results obtained or for incidental or consequential damages, including lost profits, arising from the
use of these data. No warranty against infringement of any patent, copyright or trademark is made or implied.
· Department issuing MSDS
- Abbott Diagnostics Safety, Health and Environmental Assurance
Department 0571
· Contact
- General information about this product:
Abbott Diagnostics
Technical Support
USA
37.0.4
Page 9/9
37.0.4
Page 1/9
* 1 Identification
· Product name: ARCHITECT BNP Specimen Diluent
* 2 Hazard(s) identification
· Classification of the substance or mixture
· Classification system:
The classification was made according to U.S. OSHA 29 CFR 1910.1200 and 1910.1030 and applicable
European regulations, and is expanded upon from company and/or literature data.
· Label elements
· Labelling according to EU guidelines:
· Code letter and hazard designation of product:
Xi Irritant
37.0.4
Page 2/9
* 3 Composition/information on ingredients
· Chemical characterization: Mixture of chemical and/or biological substances for in vitro diagnostic use.
· Hazardous chemical ingredients per U.S. OSHA criteria (29 CFR 1910.1200 Hazard Communication):
2682-20-4 2-Methyl-2H-isothiazol-3-one 0.0094%
* 4 First-aid measures
· General information: Immediately remove any clothing soiled by the product.
· After inhalation: Remove from source of exposure. If irritation or signs of toxicity occur, seek medical attention.
· After skin contact:
Take off any clothing that the product touched.
Rinse skin with running water for 15 to 20 minutes. Seek medical attention if irritation or signs of toxicity occur.
· After eye contact:
Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
If eye irritation persists, get medical advice/attention. Wash hands after handling.
· After swallowing: Rinse mouth with water. If irritation or signs of toxicity occur, seek medical attention.
· Information for Medical Personnel
· Most important symptoms and effects, both acute and delayed:
Allergic reactions
Possibly immune response
This product may cause skin sensitization reactions in some people. See Section 11 for additional information.
· Medical conditions aggravated by exposure:
Pre-existing skin ailments
Skin allergies
USA
37.0.4
Page 3/9
* 5 Fire-fighting measures
· Suitable extinguishing agents
Dry chemical, carbon dioxide (CO2), water spray or regular foam.
- Caution: CO2 will displace air in confined spaces and may cause an oxygen-deficient atmosphere.
- For larger fires: There are no unique chemical or reactivity hazards that would impact firefighting decisions related
to this product. Use firefighting measures that suit the environment.
· Special hazards arising from the substance or mixture
There are no unique chemical or reactivity hazards that would impact firefighting decisions due to the chemicals in this
product.
· Protective equipment
For large fires, wear appropriate heat- and flame-resistant personal protective equipment and a NFPA/NIOSH
approved positive-pressure, self-contained breathing apparatus.
37.0.4
Page 4/9
Small-volume spills (e.g. small enough to clean up with a paper towel or small sorbent pad) - respiratory protection
should not be necessary if room is well ventilated.
Other unusual conditions (e.g. volume spilled too big to clean up with materials in arm's reach) - Use appropriate
NIOSH-approved air-purifying respirator if airborne chemical concentrations may exceed the exposure limit (if any)
listed above.
37.0.4
Page 5/9
37.0.4
Page 6/9
* 11 Toxicological information
· Acute toxicity
· LD50/LC50 values for hazardous ingredients per OSHA criteria:
· Ingredients (100% pure substance/s):
2682-20-4 2-Methyl-2H-isothiazol-3-one
Oral LD50 60 mg/kg (mouse)
By analogy to methylchloroisothiazolinone.
53 mg/kg (rat)
By analogy to methylchloroisothiazolinone.
· Primary toxicological effects of the final product:
· Skin irritation: No irritant effect.
· Eye irritation: No irritant effect.
· Sensitization:
Skin sensitization is possible with prolonged exposure, based on the reported properties of methylisothiazolones.
· Additional toxicological information: None
· Carcinogenic categories
· IARC (International Agency for Research on Cancer)
None of the ingredients is listed.
· NTP (National Toxicology Program)
None of the ingredients is listed.
· Target organs/systems:
Skin
Immune system
* 12 Ecological information
· Aquatic toxicity: No further relevant information available.
USA
37.0.4
Page 7/9
* 13 Disposal considerations
· Recommendation for disposal of unused product:
Dispose in accordance with federal, state and local regulations and institutional requirements. Waste containing
this product may be considered hazardous per U.S. EPA, state or local regulations. The following may be
particularly important when identifying appropriate disposal:
- Contains sodium azide. See Section 10 when considering how to appropriately dispose of unused product. For
drain systems with pipes or solder containing copper, lead, brass and/or silver, flush drains thoroughly with
copious amounts of water to prevent the formation of potentially explosive metal azides in plumbing. Detailed
information about azides in drains is available from the U.S. NIOSH Current Intelligence Bulletin No. 13 (August
16, 1976).
· Recommendation for disposal of packaging:
Non-contaminated packaging may be used for recycling. Refer to applicable local regulations and institutional
policies.
For disposal of contaminated packaging, refer to applicable local regulations and institutional policies.
· Recommended cleansing agent: Water with cleansing agents, if necessary.
* 14 Transport information
· DOT, ADN, IMDG, IATA none
· UN proper shipping name
· DOT, ADR, ADN, IMDG, IATA none
· Transport hazard class(es)
· DOT, ADR, ADN, IMDG, IATA
· Class none
· DOT, IMDG, IATA none
· Environmental hazards
· Marine pollutant: No
· Additional information
· DOT
· Remarks: Not restricted for transportation.
· ADR
· Remarks: Not restricted for transportation.
· IMDG
· Remarks: Not restricted for transportation.
USA
37.0.4
Page 8/9
· IATA
· Remarks: Not restricted for transportation.
* 15 Regulatory information
· SARA (Superfund Amendments and Reauthorization Act of 1986 - USA):
· Section 302/304 (40CFR355.30 / 40CFR355.40):
26628-22-8 Sodium azide
· Section 313 (40CFR372.65):
26628-22-8 Sodium azide
· California Proposition 65 (USA):
· Chemicals known to cause cancer:
The product does not contain listed substances.
· Chemicals known to cause female reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause male reproductive toxicity:
None of the ingredients is listed.
· Chemicals known to cause developmental reproductive toxicity:
None of the ingredients is listed.
* 16 Other information
The information and recommendations contained herein are based upon information or tests believed to be reliable.
Abbott Laboratories does not guarantee the accuracy or completeness of this information or recommendations
contained herein, NOR SHALL ANY OF THIS INFORMATION CONSTITUTE A WARRANTY, WHETHER
EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE MERCHANTABILITY OF THE GOODS,
OR THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE.
This information is not a substitute for the advice of a health care professional, nor is it a recommendation for any
particular course of treatment. It is not intended to supplement, modify or supersede any information (e.g. labeling
and package inserts) provided with respect to the medical use of the product. Abbott Laboratories assumes no
responsibility for results obtained or for incidental or consequential damages, including lost profits, arising from the
use of these data. No warranty against infringement of any patent, copyright or trademark is made or implied.
· Department issuing MSDS
- Abbott Diagnostics Safety, Health and Environmental Assurance
Department 0571
· Contact
USA
37.0.4
Page 9/9
37.0.4